Kraig Biocraft Laboratories, Inc. (KBLB) stock: key figures, P/E, revenue and dividend
Materials · United States · ISIN US50075W1045
Kraig Biocraft Laboratories, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -3.37 m USD |
| EBIT | -3.05 m USD |
| Net income | -3.62 m USD |
| Diluted EPS – continuing operations | 0.00 USD |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. The company's primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. Its products are used in performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics, and other applications; and military and police for its ballistic protection. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.
More stocks
- Patagonia Gold Corp (PGDC.V)
- Tung Thih Electronic Co Ltd (3552.TWO)
- Cubtek Inc. (2252.TWO)
- Atlantic Sapphire As (ASA.OL)
- Taiwan Environment Scientific Co., Ltd. (8476.TW)
- Liying EPTech (7820.TWO)
- Onyx Healthcare Inc. (6569.TWO)
- Grown Rogue International Inc. (GRUSF)
- Microcosm Technology Co Ltd (3354.TWO)
- Ace Technologies Corp (088800.KQ)
- Chilean Cobalt Corp. (COBA)
- Hyosung Itx (094280.KS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.